Warm compresses are an invaluable step in the treatment of dry eye.
Ophthalmic corticosteroids optimize outcomes in patients with ocular inflammatory conditions
Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.
Adding laboratory testing and meibography helps patients and practices
Some optometrists are reluctant to incorporate myopia control into practice. With global cases on the rise, the time to act is now.
At-home devices challenge commonly held beliefs on IOP measurements, visual field testing, and imaging.
Cases illustrate how acute and chronic angle-closure glaucoma are treated
As myopia prevalence continues to increase, there is a growing concern about myopia’s economic burden and effects on children, specifically on their visual impairment and quality of life. The consequences of myopia and high myopia can be delayed by implementing myopia management therapies.
In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.
Austin Lifferth, OD, FAAO, shares highlights from his AAOpt 2022 presentations, including a triad approach to evaluating the optic nerve in glaucoma, and recentering glaucoma care with these 5 GlaucoMantras.
New technology improves precision of binocular vision disorder diagnosis and correction
This drug category is rapidly growing in the ophthalmic space, with more options in the pipeline
Collaboration between ophthalmologists, optometrists can boost early detection.
Studies suggest that high glycemic load carbohydrate diets may alter the genetic influence of growth of the sclera and choroid, which ultimately can induce permanent changes in the development and progression of myopia.
How eye care practices and doctors can prepare for the next pandemic
Neurofibromatosis type 1 (NF1) is a condition associated with significant systemic morbidity. Abnormal proliferation of cells derived from the neural crest can cause benign and malignant tumors throughout the body in NF1.
Open Your Eyes documentary now available on Apple TV+ and Google Play!
Jay M. Haynie, OD, FAAO, FORS, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from his presentation on staying current with the AMD landscape.
A single, consistent modality leads to better geographic atrophy tracking.
A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application
How eye care practices and doctors can prepare for the next pandemic
As the need for telemedicine increases, so does the urgency for creating new, less intrusive technology platforms.
Chris Kenrick, OD, shares what she finds to be most important from her discussion this year at AAOpt 2022.
Jamie Ho, OD, FAAO, FCOVD, shares highlights from her SCOPA 2022 presentation, "Tools and considerations for low vision rehabilitation."
Essence Johnson, OD, FAAO, addressed the "State of optometry," at NOA 2023 in Fort Lauderdale, Florida.
Electronic health records may be the future of practice management.
Presbyopia-correcting drops for patients with low, up-close visual function.